ADAGENE INC-ADR logo

ADAG

ADAGENE INC-ADR

$1.09

Earnings Summary

Revenue
$0.39Mn
Net Profits
$-12.77Mn
Net Profit Margins
-3261.99%

Highlights

Revenue:

ADAGENE INC-ADR’s revenue fell -18.46% since last year same period to $0.39Mn in the Q4 2020. On a quarterly growth basis, ADAGENE INC-ADR has generated +Inf% jump in its revenue since last 3-months.

Net Profits:

ADAGENE INC-ADR’s net profit fell -176.72% since last year same period to $-12.77Mn in the Q4 2020. On a quarterly growth basis, ADAGENE INC-ADR has generated -11.57% fall in its net profits since last 3-months.

Net Profit Margins:

ADAGENE INC-ADR’s net profit margin fell -239.35% since last year same period to -3261.99% in the Q4 2020. On a quarterly growth basis, ADAGENE INC-ADR has generated NaN% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the ADAGENE INC-ADR post its latest quarter earnings

EPS Estimate Current Quarter
-0.36
EPS Estimate Current Year
-0.36

Highlights

EPS Estimate Current Quarter:

ADAGENE INC-ADR’s earning per share (EPS) estimates for the current quarter stand at -0.36 - a 32.08% jump from last quarter’s estimates.

EPS Estimate Current Year:

ADAGENE INC-ADR’s earning per share (EPS) estimates for the current year stand at -0.36.

Key Ratios

Key ratios of the ADAGENE INC-ADR post its Q4 2022 earnings

Earning Per Share (EPS)
0

Highlights

Earning Per Share (EPS):

ADAGENE INC-ADR’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q4 2022. This indicates that the ADAGENE INC-ADR has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2019-03-31
0
-0.3
-Inf%

Company Information

Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs. Its proprietary pipeline is comprised of novel immunotherapy programs. Adagene has forged strategic collaborations with reputable global partners that leverage its technology in multiple approaches at the vanguard of science.

Organisation
ADAGENE INC-ADR
Headquarters
Building C14, Suzhou, China, 215123
Employees
259
Industry
Healthcare

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*